Liu, L., Wang, J., Zheng, T., Huang, Y., Yang, J., Luo, J., Li, B., Ji, J., Ma, J., Xia, Q., Yao, J., Dai, C., Kang, M., Wu, F., Zhang, C., Guo, Y., Pan, Y., Li, D., Zha, Y., Sun, Y. (2025). SHR-8068 plus adebrelimab and bevacizumab for advanced hepatocellular carcinoma (aHCC): A phase 1b/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.4093